GeneDx Holdings Corp.
Stock Forecast, Prediction & Price Target
GeneDx Holdings Corp. Financial Estimates
GeneDx Holdings Corp. Revenue Estimates
GeneDx Holdings Corp. EBITDA Estimates
GeneDx Holdings Corp. Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | ||
Revenue
% change YoY
| $212.19M N/A | $234.69M 10.60% | $202.56M -13.68% | Avg: $276.29M Low: $273.94M High: $280.65M avg. 36.39% | Avg: $327.05M Low: $324.28M High: $332.22M avg. 18.37% | ||
Net Income
% change YoY
| $-245.39M N/A | $-548.98M -123.71% | $-175.76M 67.98% | Avg: $-46.8M Low: $-38.95M High: $-37.74M avg. 73.37% | Avg: $16.89M Low: $16.71M High: $17.24M avg. 136.10% | ||
EBITDA
% change YoY
| $-424.34M N/A | $-395.6M 6.77% | $-136.46M 65.50% | Avg: $-206.98M Low: $-210.25M High: $-205.23M avg. -51.68% | Avg: $-245.02M Low: $-248.89M High: $-242.94M avg. -18.37% | ||
EPS
% change YoY
| -$74.93 N/A | -$53.63 28.42% | -$7.23 86.51% | Avg: -$1.57 Low: -$1.6 High: -$1.55 avg. 78.28% | Avg: $0.7 Low: $0.69 High: $0.71 avg. 144.26% | ||
Operating Expenses
% change YoY
| $429.54M N/A | $430.75M 0.28% | $224.28M -47.93% | Avg: $277.69M Low: $275.33M High: $282.07M avg. 23.81% | Avg: $328.71M Low: $325.92M High: $333.90M avg. 18.37% | ||
FAQ
What is GeneDx Holdings Corp. stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 104.73% in 2025-2026.
We have gathered data from 1 analysts. Their low estimate is -38.95M, average is -46.8M and high is -37.74M.
What is GeneDx Holdings Corp. stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 27.38% in 2025-2026.
We have gathered data from 3 analysts. Their low revenue estimate is $273.94M, average is $276.29M and high is $280.65M.
What is GeneDx Holdings Corp. stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 111.27% in 2025-2026.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$1.6, average is -$1.57 and high is $-1.55.
What is the best performing analyst?
In the last twelve months analysts have been covering GeneDx Holdings Corp. stock. The most successful analyst is Bill Bonello.